Clinical trials
Phase 3 Seizures trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
24 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2005 | 2 |
| 2006 | 1 |
| 2008 | 2 |
| 2009 | 3 |
| 2016 | 2 |
| 2017 | 2 |
| 2019 | 2 |
| 2020 | 3 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 2 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 13 |
| Terminated | 4 |
| Active, not recruiting | 3 |
| Enrolling by invitation | 2 |
| Not yet recruiting | 1 |
| Recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Longboard Pharmaceuticals | 3 |
| Zogenix International Limited, Inc., a subsidiary of Zogenix, Inc. | 3 |
| Eisai Inc. | 2 |
| GlaxoSmithKline | 2 |
| Novartis Pharmaceuticals | 2 |
| Sumitomo Pharma America, Inc. | 2 |
| Xenon Pharmaceuticals Inc. | 2 |
| Beth Israel Deaconess Medical Center | 1 |
| Epygenix | 1 |
| Hamilton Health Sciences Corporation | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Seizures | 24 |
| Epilepsy | 18 |
| Epilepsies, Myoclonic | 7 |
| Brain Diseases | 3 |
| Epilepsies, Partial | 3 |
| Neurodevelopmental Disorders | 3 |
| Blood Loss, Surgical | 2 |
| Hemorrhage | 2 |
| Lennox Gastaut Syndrome | 2 |
| Tuberous Sclerosis | 2 |
Trials
Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.